Lack of concordance between local investigators, angiographic core laboratory, and clinical event committee in the assessment of stent thrombosis

Circulation: Cardiovascular Interventions

Volumn 9, Issue 5, 2016, Pages

  Popma, Christopher J ^a   Sheng, Shi ^b   Korjian, Serge ^a   Daaboul, Yazan ^a   Chi, Gerald ^a   Tricoci, Pierluigi ^c   Huang, Zhen ^c   Moliterno, David J ^d   White, Harvey D ^e   Van De Werf, Frans ^f   Harrington, Robert A ^g   Wallentin, Lars ^h   Held, Claes ^h   Armstrong, Paul W ⁱ   Aylward, Philip E ^j   Strony, John ^k   Mahaffey, Kenneth W ^g   Gibson, C Michael ^a  

^a BETH ISRAEL DEACONESS MEDICAL CENTER   (United States)

^b HUAZHONG UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^c DUKE CLINICAL RESEARCH INSTITUTE   (United States)

^d UNIVERSITY OF KENTUCKY   (United States)

^e AUCKLAND CITY HOSPITAL   (New Zealand)

^f UNIVERSITY OF LEUVEN   (Belgium)

^g STANFORD UNIVERSITY SCHOOL OF MEDICINE   (United States)

^h UPPSALA UNIVERSITY   (Sweden)

ⁱ UNIVERSITY OF ALBERTA   (Canada)

^j FLINDERS UNIVERSITY   (Australia)

^k MERCK RESEARCH LABORATORIES   (United States)

more..

Author keywords

angiography; clinical trial; interobserver variability; stent; thrombosis

Indexed keywords

VORAPAXAR; LACTONE; PYRIDINE DERIVATIVE;

ACUTE CORONARY SYNDROME; ARTICLE; CEREBROVASCULAR ACCIDENT; CLINICAL ASSESSMENT; COHORT ANALYSIS; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CORE LABORATORY; CORONARY ANGIOGRAPHY; CORONARY STENT; CORONARY STENTING; HEART CATHETERIZATION; HEART INFARCTION; HEART MUSCLE REVASCULARIZATION; HOSPITAL READMISSION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MULTICENTER STUDY (TOPIC); PERCUTANEOUS CORONARY INTERVENTION; PHASE 3 CLINICAL TRIAL (TOPIC); PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL (TOPIC); SINGLE BLIND PROCEDURE; ST SEGMENT ELEVATION; STENT THROMBOSIS; ANGIOGRAPHY; ANIMAL; BLOOD VESSEL TRANSPLANTATION; CHICK EMBRYO; DRUG ELUTING STENT; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW UP; LABORATORY TECHNIQUE; MALE; OUTCOME ASSESSMENT; POSTOPERATIVE COMPLICATIONS; RANDOMIZED CONTROLLED TRIAL; REPRODUCIBILITY; STATISTICS AND NUMERICAL DATA; THROMBOSIS; UTILIZATION;

ACUTE CORONARY SYNDROME; ANGIOGRAPHY; ANIMALS; BLOOD VESSEL PROSTHESIS IMPLANTATION; CHICK EMBRYO; CLINICAL LABORATORY TECHNIQUES; DRUG-ELUTING STENTS; ELECTROCARDIOGRAPHY; FEMALE; FOLLOW-UP STUDIES; HUMANS; LACTONES; MALE; OUTCOME ASSESSMENT (HEALTH CARE); PERCUTANEOUS CORONARY INTERVENTION; POSTOPERATIVE COMPLICATIONS; PYRIDINES; REPRODUCIBILITY OF RESULTS; THROMBOSIS;

EID: 84969170520     PISSN: 19417640     EISSN: 19417632     Source Type: Journal    
DOI: 10.1161/CIRCINTERVENTIONS.115.003114     Document Type: Article

References (48)

1. Cutlip DE, Baim DS, Ho KK, Popma JJ, Lansky AJ, Cohen DJ, Carrozza JP Jr, Chauhan MS, Rodriguez O, Kuntz RE, Stent thrombosis in the modern era: a pooled analysis of multicenter coronary stent clinical trials. Circulation 2001 103 1967 1971
2. D'Ascenzo F, Bollati M, Clementi F, Castagno D, Lagerqvist B, de la Torre Hernandez JM, ten Berg JM, Brodie BR, Urban P, Jensen LO, Sardi G, Waksman R, Lasala JM, Schulz S, Stone GW, Airoldi F, Colombo A, Lemesle G, Applegate RJ, Buonamici P, Kirtane AJ, Undas A, Sheiban I, Gaita F, Sangiorgi G, Modena MG, Frati G, Biondi-Zoccai G, Incidence and predictors of coronary stent thrombosis: evidence from an international collaborative meta-Analysis including 30 studies, 221,066 patients, and 4276 thromboses. Int J Cardiol 2013 167 575 584. doi: 10.1016/j.ijcard.2012.01.080.
3. Moreno R, Fernández C, Hernández R, Alfonso F, Angiolillo DJ, Sabaté M, Escaned J, Bañuelos C, Fernández-Ortiz A, Macaya C, Drug-eluting stent thrombosis: results from a pooled analysis including 10 randomized studies. J Am Coll Cardiol 2005 45 954 959. doi: 10.1016/j.jacc.2004.11.065.
4. Serruys PW, Unger F, Sousa JE, Jatene A, Bonnier HJ, Schönberger JP, Buller N, Bonser R, van den Brand MJ, van Herwerden LA, Morel MA, van Hout BA, Arterial Revascularization Therapies Study Group Comparison of coronary-Artery bypass surgery and stenting for the treatment of multivessel disease. N Engl J Med 2001 344 1117 1124. doi: 10.1056/NEJM200104123441502.
5. Silber S, Windecker S, Vranckx P, Serruys PW, RESOLUTE All Comers Investigators Unrestricted randomised use of two new generation drug-eluting coronary stents: 2-year patient-related versus stent-related outcomes from the RESOLUTE All Comers trial. Lancet 2011 377 1241 1247. doi: 10.1016/S0140-6736(11)60395-4.
6. Park DW, Kim YH, Yun SC, Kang SJ, Lee SW, Lee CW, Park SW, Seong IW, Lee JH, Tahk SJ, Jeong MH, Jang Y, Cheong SS, Yang JY, Lim DS, Seung KB, Chae JK, Hur SH, Lee SG, Yoon J, Lee NH, Choi YJ, Kim HS, Kim KS, Kim HS, Hong TJ, Park HS, Park SJ, Comparison of zotarolimus-eluting stents with sirolimus-And paclitaxel-eluting stents for coronary revascularization: the ZEST (Comparison of the Efficacy and the Safety of Zotarolimus-Eluting Stent Versus Sirolimus-Eluting Stent and Paclitaxel-Eluting Stent for Coronary Lesions) randomized trial. J Am Coll Cardiol 2010 56 1187 1195. doi: 10.1016/j.jacc.2010.03.086.
7. Leon MB, Mauri L, Popma JJ, Cutlip DE, Nikolsky E, O'Shaughnessy C, Overlie PA, McLaurin BT, Solomon SL, Douglas JS Jr, Ball MW, Caputo RP, Jain A, Tolleson TR, Reen BM III, Kirtane AJ, Fitzgerald PJ, Thompson K, Kandzari DE, ENDEAVOR IV Investigators A randomized comparison of the Endeavor zotarolimus-eluting stent versus the TAXUS paclitaxel-eluting stent in de novo native coronary lesions 12-month outcomes from the ENDEAVOR IV trial. J Am Coll Cardiol 2010 55 543 554. doi: 10.1016/j.jacc.2009.08.067.
8. Stone GW, Rizvi A, Sudhir K, Newman W, Applegate RJ, Cannon LA, Maddux JT, Cutlip DE, Simonton CA, Sood P, Kereiakes DJ, SPIRIT IV Investigators Randomized comparison of everolimus-And paclitaxel-eluting stents. 2-year follow-up from the SPIRIT (Clinical Evaluation of the XIENCE V Everolimus Eluting Coronary Stent System) IV trial. J Am Coll Cardiol 2011 58 19 25. doi: 10.1016/j.jacc.2011.02.022.
9. Kedhi E, Joesoef KS, McFadden E, Wassing J, van Mieghem C, Goedhart D, Smits PC, Second-generation everolimus-eluting and paclitaxel-eluting stents in real-life practice (COMPARE): a randomised trial. Lancet 2010 375 201 209. doi: 10.1016/S0140-6736(09)62127-9.
10. Palmerini T, Kirtane AJ, Serruys PW, Smits PC, Kedhi E, Kereiakes D, Sangiorgi D, Bacchi Reggiani L, Kaiser C, Kim HS, De Waha A, Ribichini F, Stone GW, Stent thrombosis with everolimus-eluting stents: meta-Analysis of comparative randomized controlled trials. Circ Cardiovasc Interv 2012 5 357 364. doi: 10.1161/CIRCINTERVENTIONS.111.967083.
11. de la Torre-Hernandez JM, Alfonso F, Hernandez F, Elizaga J, Sanmartin M, Pinar E, Lozano I, Vazquez JM, Botas J, Perez de Prado A, Hernández JM, Sanchis J, Nodar JM, Gomez-Jaume A, Larman M, Diarte JA, Rodríguez-Collado J, Rumoroso JR, Lopez-Minguez JR, Mauri J, Drug-eluting stent thrombosis: results from the multicenter Spanish registry ESTROFA (Estudio Espanol Sobre Trombosis de Stents Farmacoactivos). J Am Coll Cardiol 2008 51 986 990
12. Doyle B, Rihal CS, O'Sullivan CJ, Lennon RJ, Wiste HJ, Bell M, Bresnahan J, Holmes DR Jr., Outcomes of stent thrombosis and restenosis during extended follow-up of patients treated with bare-metal coronary stents. Circulation 2007 116 2391 2398. doi: 10.1161/CIRCULATIONAHA.107.707331.
13. Gallego L, Martínez-Sellés M, García E, Franco J, Estévez A, Sarnago Cebada F, Fernández-Avilés F, Characteristics and outcome of angiographically confirmed stent thrombosis. Rev Esp Cardiol 2009 62 220 223
14. Kuchulakanti PK, Chu WW, Torguson R, Ohlmann P, Rha SW, Clavijo LC, Kim SW, Bui A, Gevorkian N, Xue Z, Smith K, Fournadjieva J, Suddath WO, Satler LF, Pichard AD, Kent KM, Waksman R, Correlates and long-Term outcomes of angiographically proven stent thrombosis with sirolimus-And paclitaxel-eluting stents. Circulation 2006 113 1108 1113. doi: 10.1161/CIRCULATIONAHA.105.600155.
15. Mauri L, Hsieh WH, Massaro JM, Ho KK, D'Agostino R, Cutlip DE, Stent thrombosis in randomized clinical trials of drug-eluting stents. N Engl J Med 2007 356 1020 1029. doi: 10.1056/NEJMoa067731.
16. van Werkum JW, Heestermans AA, de Korte FI, Kelder JC, Suttorp MJ, Rensing BJ, Zwart B, Brueren BR, Koolen JJ, Dambrink JH, van't Hof AW, Verheugt FW, ten Berg JM, Long-Term clinical outcome after a first angiographically confirmed coronary stent thrombosis: an analysis of 431 cases. Circulation 2009 119 828 834. doi: 10.1161/CIRCULATIONAHA.108.799403.
17. Wenaweser P, Rey C, Eberli FR, Togni M, Tüller D, Locher S, Remondino A, Seiler C, Hess OM, Meier B, Windecker S, Stent thrombosis following bare-metal stent implantation: success of emergency percutaneous coronary intervention and predictors of adverse outcome. Eur Heart J 2005 26 1180 1187. doi: 10.1093/eurheartj/ehi135.
18. Wiviott SD, Braunwald E, McCabe CH, Horvath I, Keltai M, Herrman JP, Van de Werf F, Downey WE, Scirica BM, Murphy SA, Antman EM, TRITON-TIMI 38 Investigators Intensive oral antiplatelet therapy for reduction of ischaemic events including stent thrombosis in patients with acute coronary syndromes treated with percutaneous coronary intervention and stenting in the TRITON-TIMI 38 trial: a subanalysis of a randomised trial. Lancet 2008 371 1353 1363. doi: 10.1016/S0140-6736(08)60422-5.
19. Sianos G, Papafaklis MI, Daemen J, Vaina S, van Mieghem CA, van Domburg RT, Michalis LK, Serruys PW, Angiographic stent thrombosis after routine use of drug-eluting stents in ST-segment elevation myocardial infarction: the importance of thrombus burden. J Am Coll Cardiol 2007 50 573 583. doi: 10.1016/j.jacc.2007.04.059.
20. Cutlip DE, Windecker S, Mehran R, Boam A, Cohen DJ, van Es GA, Steg PG, Morel MA, Mauri L, Vranckx P, McFadden E, Lansky A, Hamon M, Krucoff MW, Serruys PW, Academic Research Consortium Clinical end points in coronary stent trials: a case for standardized definitions. Circulation 2007 115 2344 2351. doi: 10.1161/CIRCULATIONAHA.106.685313.
21. Serruys PW, Onuma Y, Garg S, Sarno G, van den Brand M, Kappetein AP, Van Dyck N, Mack M, Holmes D, Feldman T, Morice MC, Colombo A, Bass E, Leadley K, Dawkins KD, van Es GA, Morel MA, Mohr FW, Assessment of the SYNTAX score in the Syntax study. EuroIntervention 2009 5 50 56
22. Gibson CM, Cannon CP, Daley WL, Dodge JT Jr, Alexander B Jr, Marble SJ, McCabe CH, Raymond L, Fortin T, Poole WK, Braunwald E, TIMI frame count: a quantitative method of assessing coronary artery flow. Circulation 1996 93 879 888
23. Tanboga IH, Ekinci M, Isik T, Kurt M, Kaya A, Sevimli S, Reproducibility of syntax score: from core lab to real world. J Interv Cardiol 2011 24 302 306. doi: 10.1111/j.1540-8183.2011.00645.x.
24. Garg S, Girasis C, Sarno G, Goedhart D, Morel MA, Garcia-Garcia HM, Bressers M, van Es GA, Serruys PW, SYNTAX Trial Investigators The SYNTAX score revisited: a reassessment of the SYNTAX score reproducibility. Catheter Cardiovasc Interv 2010 75 946 952. doi: 10.1002/ccd.22372.
25. Vijayaraghavan R, Yan AT, Tan M, Fitchett DH, Georgescu AA, Hassan Q, Langer A, Goodman SG, Canadian Acute Coronary Syndromes Registry Investigators Local hospital vs. core-laboratory interpretation of the admission electrocardiogram in acute coronary syndromes: increased mortality in patients with unrecognized ST-elevation myocardial infarction. Eur Heart J 2008 29 31 37. doi: 10.1093/eurheartj/ehm503.
26. Holmvang L, Hasbak P, Clemmensen P, Wagner G, Grande P, Differences between local investigator and core laboratory interpretation of the admission electrocardiogram in patients with unstable angina pectoris or non-Q-wave myocardial infarction (a thrombin inhibition in myocardial ischemia [TRIM] substudy). Am J Cardiol 1998 82 54 60
27. Renaud JM, Mylonas I, McArdle B, Dowsley T, Yip K, Turcotte E, Guimond J, Trottier M, Pibarot P, Maguire C, Lalonde L, Gulenchyn K, Wisenberg G, Wells RG, Ruddy T, Chow B, Beanlands RS, deKemp RA, Clinical interpretation standards and quality assurance for the multicenter PET/CT trial rubidium-ARMI. J Nucl Med 2014 55 58 64. doi: 10.2967/jnumed.112.117515.
28. Johansen A, Høilund-Carlsen PF, Christensen HW, Grupe P, Veje A, Vach W, Haghfelt T, Observer variability in the evaluation of dual-isotope Tl-201/Tc-99m sestamibi rest/stress myocardial perfusion SPECT in men and women with known or suspected stable angina pectoris. J Nucl Cardiol 2004 11 710 718
29. Popma JJ, Lansky AJ, Yeh W, Kennard ED, Keller MB, Merritt AJ, DeFalco RA, Desai A, Pacera JH, Schnabel JF, Niedermeyer V, Baim DS, Detre KM, Reliability of the quantitative angiographic measurements in the new approaches to coronary intervention (NACI) registry: a comparison of clinical site and repeated angiographic core laboratory readings. Am J Cardiol 1997 80 19K 25K
30. Kleiman NS, Rodriguez AR, Raizner AE, Interobserver variability in grading of coronary arterial narrowings using the American College of Cardiology/American Heart Association grading criteria. Am J Cardiol 1992 69 413 415
31. Leonardi S, Truffa AA, Neely ML, Tricoci P, White HD, Gibson CM, Wilson M, Stone GW, Harrington RA, Bhatt DL, Mahaffey KW, A novel approach to systematically implement the universal definition of myocardial infarction: insights from the CHAMPION PLATFORM trial. Heart 2013 99 1282 1287. doi: 10.1136/heartjnl-2012-303103.
32. Mahaffey KW, Held C, Wojdyla DM, James SK, Katus HA, Husted S, Steg PG, Cannon CP, Becker RC, Storey RF, Khurmi NS, Nicolau JC, Yu CM, Ardissino D, Budaj A, Morais J, Montgomery D, Himmelmann A, Harrington RA, Wallentin L, PLATO Investigators Ticagrelor effects on myocardial infarction and the impact of event adjudication in the PLATO (Platelet Inhibition and Patient Outcomes) trial. J Am Coll Cardiol 2014 63 1493 1499. doi: 10.1016/j.jacc.2014.01.038.
33. Mahaffey KW, Wampole JL, Stebbins A, Berdan LG, McAfee D, Rorick TL, French JK, Kleiman NS, O'Connor CM, Cohen EA, Granger CB, Armstrong PW, APEX-AMI Investigators Strategic lessons from the clinical event classification process for the assessment of pexelizumab in acute myocardial infarction (APEX-AMI) trial. Contemp Clin Trials 2011 32 178 187. doi: 10.1016/j.cct.2010.12.013.
34. Mahaffey KW, Roe MT, Dyke CK, Newby LK, Kleiman NS, Connolly P, Berdan LG, Sparapani R, Lee KL, Armstrong PW, Topol EJ, Califf RM, Harrington RA, Misreporting of myocardial infarction end points: results of adjudication by a central clinical events committee in the PARAGON-B trial. Second platelet IIb/IIIa antagonist for the reduction of acute coronary syndrome events in a global organization network trial. Am Heart J 2002 143 242 248
35. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, for the PURSUIT Investigators Disagreements between central clinical events committee and site investigator assessments of myocardial infarction endpoints in an international clinical trial: review of the PURSUIT study. Curr Control Trials Cardiovasc Med 2001 2 187 194. doi: 10.1186/cvm-2-4-187.
36. Mahaffey KW, Harrington RA, Akkerhuis M, Kleiman NS, Berdan LG, Crenshaw BS, Tardiff BE, Granger CB, DeJong I, Bhapkar M, Widimsky P, Corbalon R, Lee KL, Deckers JW, Simoons ML, Topol EJ, Califf RM, for the PURSUIT Investigators Systematic adjudication of myocardial infarction end-points in an international clinical trial. Curr Control Trials Cardiovasc Med 2001 2 180 186. doi: 10.1186/cvm-2-4-180.
37. Carson P, Fiuzat M, O'Connor C, Anand I, Plehn J, Lindenfeld JA, Silver M, White M, Miller A, Davis G, Robertson AD, Bristow M, Gottlieb S, Determination of hospitalization type by investigator case report form or adjudication committee in a large heart failure clinical trial (β-Blocker Evaluation of Survival Trial [BEST]). Am Heart J 2010 160 649 654. doi: 10.1016/j.ahj.2010.07.004.
38. O'Connor CM, Fiuzat M, Lindenfeld J, Miller A, Lombardi C, Carson P, Shaw LK, Wang LJ, Connolly P, Mills R, Yancy C, Mahaffey K, Mode of death and hospitalization from the second follow-up serial infusions of nesiritide (FUSION II) trial and comparison of clinical events committee adjudicated versus investigator reported outcomes. Am J Cardiol 2011 108 1449 1457. doi: 10.1016/j.amjcard.2011.06.065.
39. Petersen JL, Haque G, Hellkamp AS, Flaker GC, Mark Estes NA III, Marchlinski FE, McAnulty JH, Greenspon AJ, Marinchak RA, Lee KL, Lamas GA, Mahaffey KW, MOST Clinical Events Committee Comparing classifications of death in the Mode Selection Trial: agreement and disagreement among site investigators and a clinical events committee. Contemp Clin Trials 2006 27 260 268. doi: 10.1016/j.cct.2006.02.002.
40. Näslund U, Grip L, Fischer-Hansen J, Gundersen T, Lehto S, Wallentin L, The impact of an end-point committee in a large multicentre, randomized, placebo-controlled clinical trial: results with and without the end-point committee's final decision on end-points. Eur Heart J 1999 20 771 777
41. The Thrombolysis In Myocardial Infarction (TIMI) trial. Phase I findings. TIMI Study Group. N Engl J Med 1985 312 932 936
42. Gibson CM, Cannon CP, Murphy SA, Ryan KA, Mesley R, Marble SJ, McCabe CH, Van De Werf F, Braunwald E, Relationship of TIMI myocardial perfusion grade to mortality after administration of thrombolytic drugs. Circulation 2000 101 125 130
43. Gibson CM, de Lemos JA, Murphy SA, Marble SJ, McCabe CH, Cannon CP, Antman EM, Braunwald E, TIMI Study Group Combination therapy with abciximab reduces angiographically evident thrombus in acute myocardial infarction: a TIMI 14 substudy. Circulation 2001 103 2550 2554
44. Tricoci P, Huang Z, Held C, Moliterno DJ, Armstrong PW, Van de Werf F, White HD, Aylward PE, Wallentin L, Chen E, Lokhnygina Y, Pei J, Leonardi S, Rorick TL, Kilian AM, Jennings LH, Ambrosio G, Bode C, Cequier A, Cornel JH, Diaz R, Erkan A, Huber K, Hudson MP, Jiang L, Jukema JW, Lewis BS, Lincoff AM, Montalescot G, Nicolau JC, Ogawa H, Pfisterer M, Prieto JC, Ruzyllo W, Sinnaeve PR, Storey RF, Valgimigli M, Whellan DJ, Widimsky P, Strony J, Harrington RA, Mahaffey KW, TRACER Investigators Thrombin-receptor antagonist vorapaxar in acute coronary syndromes. N Engl J Med 2012 366 20 33. doi: 10.1056/NEJMoa1109719.
45. Sianos G, Morel MA, Kappetein AP, Morice MC, Colombo A, Dawkins K, van den Brand M, Van Dyck N, Russell ME, Mohr FW, Serruys PW, The SYNTAX score: an angiographic tool grading the complexity of coronary artery disease. EuroIntervention 2005 1 219 227
46. Tjandrawidjaja MC, Fu Y, Al-Khalidi H, Todaro TG, Adams P, Van de Werf F, Granger CB, Armstrong PW, APEX-AMI Investigators Failure of investigator adherence to electrocardiographic entry criteria is frequent and influences clinical outcomes: lessons from APEX-AMI. Eur Heart J 2007 28 2850 2857. doi: 10.1093/eurheartj/ehm453.
47. Vranckx P, McFadden E, Cutlip DE, Mehran R, Swart M, Kint PP, Zijlstra F, Silber S, Windecker S, Serruys PW, Clinical endpoint adjudication in a contemporary all-comers coronary stent investigation: methodology and external validation. Contemp Clin Trials 2013 34 53 59. doi: 10.1016/j.cct.2012.08.012.
48. Cutlip DE, Nakazawa G, Krucoff MW, Vorpahl M, Mehran R, Finn AV, Vranckx P, Kimmelstiel C, Berger C, Petersen JL, Palabrica T, Virmani R, Autopsy validation study of the Academic Research Consortium stent thrombosis definition. JACC Cardiovasc Interv 2011 4 554 559. doi: 10.1016/j.jcin.2011.01.011.